Lisa Hicks

MD, MSc

Investigator

Biography

Dr. Lisa Hicks is a malignant hematologist at St. Michael’s Hospital with an academic focus in health services research and quality improvement. She uses traditional clinical epidemiology methods combined with quality improvement techniques to develop interventions to improve the safety and efficiency of patient care. Thematically, her work focuses on understanding drivers of over-utilization in healthcare and on developing strategies to decrease this phenomenon. She also has an interest in optimizing the safety of cancer treatments. In particular, Dr. Hicks leads research that aims to understand the risk of COVID-19 in patients with blood cancer and how to optimize vaccination in this population. Dr. Hicks is also an active contributor to the development of clinical practice guidelines. She collaborates in this work with Cancer Care Ontario (CCO) and the American Society of Hematology (ASH). Finally, Dr. Hicks has a large clinical practice in Human Immunodeficiency Virus (HIV) associated lymphoma and has led clinical studies in this area.

Dr. Hicks is the Chair of the Committee on Quality, for the American Society of Hematology (ASH) and is past-chair of the ASH Choosing Wisely Task Force. Dr. Hicks is the St. Michael’s Hospital Lead for a Hospital initiative addressing overutilization

Recent Publications

  1. Desai, A, Mohammed, TJ, Duma, N, Garassino, MC, Hicks, LK, Kuderer, NM et al.. COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response. JAMA Oncol. 2021; :. doi: 10.1001/jamaoncol.2021.4083. PubMed PMID:34473192 .
  2. Vijenthira, A, Gong, I, Betschel, SD, Cheung, M, Hicks, LK. Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients. Blood Adv. 2021;5 (12):2624-2643. doi: 10.1182/bloodadvances.2021004629. PubMed PMID:34152403 PubMed Central PMC8216656.
  3. O'Brien, SH, Badawy, SM, Rotz, SJ, Shah, MD, Makarski, J, Bercovitz, RS et al.. The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Pediatr Blood Cancer. 2021;68 (8):e28967. doi: 10.1002/pbc.28967. PubMed PMID:34047047 .
  4. Mohammed-Ali, Z, Bhandarkar, S, Tahir, S, Handford, C, Yip, D, Beriault, D et al.. Implementing effective test utilization via team-based evaluation and revision of a family medicine laboratory test requisition. BMJ Open Qual. 2021;10 (1):. doi: 10.1136/bmjoq-2020-001219. PubMed PMID:33731485 PubMed Central PMC7978073.
  5. Beriault, DR, Gilmour, JA, Hicks, LK. Overutilization in laboratory medicine: tackling the problem with quality improvement science. Crit Rev Clin Lab Sci. 2021;58 (6):430-446. doi: 10.1080/10408363.2021.1893642. PubMed PMID:33691585 .
  6. Lyman, GH, Carrier, M, Ay, C, Di Nisio, M, Hicks, LK, Khorana, AA et al.. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5 (4):927-974. doi: 10.1182/bloodadvances.2020003442. PubMed PMID:33570602 PubMed Central PMC7903232.
  7. Bodley, T, Chan, M, Levi, O, Clarfield, L, Yip, D, Smith, O et al.. Patient harm associated with serial phlebotomy and blood waste in the intensive care unit: A retrospective cohort study. PLoS One. 2021;16 (1):e0243782. doi: 10.1371/journal.pone.0243782. PubMed PMID:33439871 PubMed Central PMC7806151.
  8. Wood, WA, Neuberg, DS, Thompson, JC, Tallman, MS, Sekeres, MA, Sehn, LH et al.. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub. Blood Adv. 2020;4 (23):5966-5975. doi: 10.1182/bloodadvances.2020003170. PubMed PMID:33278301 PubMed Central PMC7724912.
  9. Vijenthira, A, Gong, IY, Fox, TA, Booth, S, Cook, G, Fattizzo, B et al.. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136 (25):2881-2892. doi: 10.1182/blood.2020008824. PubMed PMID:33113551 PubMed Central PMC7746126.
  10. May, JE, Irelan, PC, Boedeker, K, Cahill, E, Fein, S, Garcia, DA et al.. Systems-based hematology: highlighting successes and next steps. Blood Adv. 2020;4 (18):4574-4583. doi: 10.1182/bloodadvances.2020002947. PubMed PMID:32960959 PubMed Central PMC7509880.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Department of Medicine, St. Michael’s Hospital
  • Associate Professor, Department of Medicine, University of Toronto
X